Literature DB >> 1974553

HLA antigens in Japanese patients with myasthenia gravis.

K Matsuki1, T Juji, K Tokunaga, M Takamizawa, H Maeda, M Soda, Y Nomura, M Segawa.   

Abstract

HLA antigens in 104 Japanese patients and 41 families with myasthenia gravis (MG) were investigated. The frequencies of DR9 and DRw13 were significantly increased in the patients who developed MG before 3 yr of age. The DQw3 antigen was positive for all the patients that developed MG before 15 yr with only one exception. All the examined cases that developed MG before 3 yr (including this DQw3 negative patient) had the same DQA and DQB DNA restriction fragments. These HLA frequencies decreased as the age of onset increased, and no significant association was observed in adult-onset MG. No patients had B8, DR3, and DQw2. The relative risk was higher for the DR9/DRw13 heterozygotes (37.4) than for DR9 (16.4) or DRw13 (7.1) in the childhood-onset MG. Statistical analysis suggested that DR9 and DRw13 (or DQw1 and DQw3) act synergistically in the disease development. Family study revealed diverse DR9 haplotypes. The most frequent DRw13 haplotype was Bw44-BFF-C4A3B1-DRw13-DQw1, which may be evolutionarily related to the caucasian B8-DR3-DQw2 haplotype. These results showed that MG in early childhood in Japanese individuals is genetically different from that in adulthood and that in caucasians.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974553      PMCID: PMC296740          DOI: 10.1172/JCI114724

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  The estimation of synergy or antagonism.

Authors:  K J Rothman
Journal:  Am J Epidemiol       Date:  1976-05       Impact factor: 4.897

3.  HLA antigens and myasthenia gravis in Japan.

Authors:  T Yoshida; M Tsuchiya; A Ono; H Yoshimatsu; E Satoyoshi; K Tsuji
Journal:  J Neurol Sci       Date:  1977-06       Impact factor: 3.181

4.  Three-allele synergistic mixed model for insulin-dependent diabetes mellitus.

Authors:  E J Louis; G Thomson
Journal:  Diabetes       Date:  1986-09       Impact factor: 9.461

Review 5.  HLA studies in diabetes mellitus: a review.

Authors:  J Nerup
Journal:  Adv Metab Disord       Date:  1978

6.  A review of theoretical aspects of HLA and disease associations.

Authors:  G Thomson
Journal:  Theor Popul Biol       Date:  1981-10       Impact factor: 1.570

7.  Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.

Authors:  K Matsuki; T Juji; K Tokunaga; T Naohara; M Satake; Y Honda
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

8.  Strong association of HLA BW46 with juvenile onset myasthenia gravis in Hong Kong Chinese.

Authors:  B R Hawkins; W Y Chan-Lui; E K Choi; A Y Ho
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

9.  Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis.

Authors:  F Naeim; J C Keesey; C Herrmann; J Lindstrom; E Zeller; R L Walford
Journal:  Tissue Antigens       Date:  1978-11

10.  Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice.

Authors:  S Hirose; G Ueda; K Noguchi; T Okada; I Sekigawa; H Sato; T Shirai
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

View more
  17 in total

1.  Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides.

Authors:  G Futaki; H Kobayashi; K Sato; M Taneichi; M Katagiri
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  Long-term outcome of 424 childhood-onset myasthenia gravis patients.

Authors:  Mengcui Gui; Xuan Luo; Jing Lin; Yue Li; Min Zhang; Xiaofan Zhang; Mingshan Yang; Wei Wang; Bitao Bu
Journal:  J Neurol       Date:  2015-01-15       Impact factor: 4.849

3.  Clinical and serological study of myasthenia gravis in HuBei Province, China.

Authors:  Xiaofan Zhang; Mingshan Yang; Jinzhi Xu; Min Zhang; Bethan Lang; Wei Wang; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-06       Impact factor: 10.154

4.  Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese.

Authors:  W H Chen; H C Chiu; R P Hseih
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

Review 5.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

6.  Genetics of microscopic polyangiitis in the Japanese population.

Authors:  Naoyuki Tsuchiya
Journal:  Ann Vasc Dis       Date:  2012

Review 7.  Genetics of ANCA-associated vasculitis in Japan: a role for HLA-DRB1*09:01 haplotype.

Authors:  Naoyuki Tsuchiya
Journal:  Clin Exp Nephrol       Date:  2012-11-23       Impact factor: 2.801

8.  Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

Authors:  J S Yi; A Guidon; S Sparks; R Osborne; V C Juel; J M Massey; D B Sanders; K J Weinhold; J T Guptill
Journal:  J Autoimmun       Date:  2013-12-28       Impact factor: 7.094

9.  Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.

Authors:  Aya Kawasaki; Narumi Hasebe; Misaki Hidaka; Fumio Hirano; Ken-Ei Sada; Shigeto Kobayashi; Hidehiro Yamada; Hiroshi Furukawa; Kunihiro Yamagata; Takayuki Sumida; Nobuyuki Miyasaka; Shigeto Tohma; Shoichi Ozaki; Seiichi Matsuo; Hiroshi Hashimoto; Hirofumi Makino; Yoshihiro Arimura; Masayoshi Harigai; Naoyuki Tsuchiya
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

10.  CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.

Authors:  Liang Sun; Yunxiao Meng; Yanchen Xie; Hua Zhang; Zheng Zhang; Xiaoxia Wang; Bin Jiang; Wei Li; Yao Li; Ze Yang
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.